[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 80, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2025, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 78, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2025, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 65, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2025, "totalPay": 607500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 57, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2025, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 70, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 71, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.712, "open": 0.768, "dayLow": 0.7, "dayHigh": 0.768, "regularMarketPreviousClose": 0.712, "regularMarketOpen": 0.768, "regularMarketDayLow": 0.7, "regularMarketDayHigh": 0.768, "payoutRatio": 0.0, "beta": 1.524, "forwardPE": 0.24345163, "volume": 473647, "regularMarketVolume": 473647, "averageVolume": 840291, "averageVolume10days": 435920, "averageDailyVolume10Day": 435920, "bid": 0.7271, "ask": 0.7852, "bidSize": 1, "askSize": 1, "marketCap": 16887490, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 2.97, "allTimeHigh": 937.5, "allTimeLow": 0.63, "fiftyDayAverage": 0.97294, "twoHundredDayAverage": 1.15945, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23208178, "profitMargins": 0.0, "floatShares": 18809957, "sharesOutstanding": 22376427, "sharesShort": 2922542, "sharesShortPriorMonth": 2628101, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.1306, "heldPercentInsiders": 0.023740001, "heldPercentInstitutions": 0.1039, "shortRatio": 2.04, "shortPercentOfFloat": 0.13520001, "impliedSharesOutstanding": 22376427, "bookValue": 3.739, "priceToBook": 0.20184541, "lastFiscalYearEnd": 1759190400, "nextFiscalYearEnd": 1790726400, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -37433912, "trailingEps": -3.38, "forwardEps": 3.1, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.602, "52WeekChange": -0.7362963, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 0.7547, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 4252290, "totalCashPerShare": 0.205, "ebitda": -38524176, "totalDebt": 1813273, "quickRatio": 0.095, "currentRatio": 0.622, "debtToEquity": 2.339, "returnOnAssets": -0.19450001, "returnOnEquity": -0.52418, "freeCashflow": -23379008, "operatingCashflow": -26552738, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Citius Pharmaceuticals, Inc.", "longName": "Citius Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1770420317, "regularMarketTime": 1770411602, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": -2.676562, "postMarketPrice": 0.7345, "postMarketChange": -0.020200014, "regularMarketChange": 0.0427, "regularMarketDayRange": "0.7 - 0.768", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 840291, "regularMarketChangePercent": 5.99719, "regularMarketPrice": 0.7547, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.12470001, "fiftyTwoWeekLowChangePercent": 0.19793652, "fiftyTwoWeekRange": "0.63 - 2.97", "fiftyTwoWeekHighChange": -2.2153, "fiftyTwoWeekHighChangePercent": -0.7458923, "fiftyTwoWeekChangePercent": -73.62963, "dividendDate": 1496966400, "earningsTimestamp": 1766523600, "earningsTimestampStart": 1770930000, "earningsTimestampEnd": 1770930000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.38, "epsForward": 3.1, "epsCurrentYear": 1.9, "priceEpsCurrentYear": 0.39721054, "fiftyDayAverageChange": -0.21824002, "fiftyDayAverageChangePercent": -0.22430985, "twoHundredDayAverageChange": -0.40475005, "twoHundredDayAverageChangePercent": -0.34908795, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]